ArticleStem cell research & therapy2020

Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy.

Pei-Hsun Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.